TECX insider filings

Tectonic Therapeutic, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-10-28. Screen TECX transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 12 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
McNamara Peter — Chief Scientific Officer3—2 legs · 579 sh · $13,9204
REICIN ALISE — Chief Executive Officer, Director3——4
Lochner Daniel — Chief Financial Officer2——2
Ruddy Marcella K. — Chief Medical Officer2——2
Schwabish Marc — Chief Business Officer2——2

Recent insider filings — Tectonic Therapeutic, Inc.

FiledFormInsiderReported transactionsSource
2026-10-284REICIN ALISE — Chief Executive Officer, DirectorOption exercise (M): 10,000 @ $2.38 · Option exercise (M): 10,000 (derivative)EDGAR
2026-10-024Lochner Daniel — Chief Financial OfficerTax withholding (F): 520 @ $23.67EDGAR
2026-10-024McNamara Peter — Chief Scientific OfficerTax withholding (F): 444 @ $23.67 · Sale (S): 536 @ $23.04EDGAR
2026-10-024Ruddy Marcella K. — Chief Medical OfficerTax withholding (F): 525 @ $23.67EDGAR
2026-10-024Schwabish Marc — Chief Business OfficerTax withholding (F): 411 @ $23.67EDGAR
2026-10-024REICIN ALISE — Chief Executive Officer, DirectorTax withholding (F): 1,545 @ $23.67EDGAR
2026-09-084REICIN ALISE — Chief Executive Officer, DirectorGrant/award (A): 69,250 (derivative) @ $0EDGAR
2026-09-084Ruddy Marcella K. — Chief Medical OfficerGrant/award (A): 24,250 (derivative) @ $0EDGAR
2026-09-084Lochner Daniel — Chief Financial OfficerGrant/award (A): 24,250 (derivative) @ $0EDGAR
2026-09-084McNamara Peter — Chief Scientific OfficerGrant/award (A): 21,000 (derivative) @ $0EDGAR
2026-09-084Schwabish Marc — Chief Business OfficerGrant/award (A): 17,750 (derivative) @ $0EDGAR
2026-08-264McNamara Peter — Chief Scientific OfficerOption exercise (M): 43 @ $14.71 · Sale (S): 43 @ $36.52 · Option exercise (M): 43 (derivative) @ $0EDGAR
2026-08-144McNamara Peter — Chief Scientific OfficerOption exercise (M): 43 @ $14.71 · Sale (S): 43 @ $35 · Option exercise (M): 43 (derivative) @ $0EDGAR
2026-07-014McNamara Peter — Chief Scientific OfficerOption exercise (M): 172 @ $14.71 · Sale (S): 172 @ $35 · Option exercise (M): 172 (derivative) @ $0EDGAR
2026-06-234REICIN ALISE — Chief Executive Officer, DirectorTax withholding (F): 924 @ $30.34EDGAR
2026-06-124Lochner Daniel — Chief Financial OfficerGrant/award (A): 7,500 (derivative) @ $0EDGAR
2026-06-104Chutter Jessica Caroline — DirectorGrant/award (A): 20,400 (derivative) @ $0EDGAR
2026-06-104Vitorovic Stefan — DirectorGrant/award (A): 10,200 (derivative) @ $0EDGAR
2026-06-104Tipirneni Praveen P. — DirectorGrant/award (A): 10,200 (derivative) @ $0EDGAR
2026-06-104Donenberg Phillip B. — DirectorGrant/award (A): 10,200 (derivative) @ $0EDGAR
2026-06-104SPRINGER TIMOTHY A — Director, 10% ownerGrant/award (A): 10,200 (derivative) @ $0EDGAR
2026-05-064Ruddy Marcella K. — Chief Medical OfficerSale (S): 1,065 @ $30EDGAR
2026-04-034Ruddy Marcella K. — Chief Medical OfficerSale (S): 1,000 @ $31.05EDGAR
2026-04-034Nader Francois — DirectorGrant/award (A): 20,400 (derivative) @ $0EDGAR
2026-03-094Ruddy Marcella K. — Chief Medical OfficerSale (S): 10,000 @ $30EDGAR
2026-03-094McNamara Peter — Chief Scientific OfficerOption exercise (M): 2,500 @ $2.38 · Option exercise (M): 215 @ $14.71 · Sale (S): 6,047 @ $30 · Sale (S): 215 @ $35 · Option exercise (M): 2,500 (derivative) · Option exercise (M): 215 (derivative) @ $0EDGAR
2026-03-054Ruddy Marcella K. — Chief Medical OfficerGrant/award (A): 26,500 @ $0 · Grant/award (A): 24,250 (derivative) @ $0EDGAR
2026-03-054McNamara Peter — Chief Scientific OfficerSale (S): 1,649 @ $22.06 · Grant/award (A): 23,000 @ $0 · Sale (S): 1,650 @ $25 · Grant/award (A): 21,000 (derivative) @ $0EDGAR
2026-03-054Schwabish Marc — Chief Business OfficerGrant/award (A): 19,500 @ $0 · Grant/award (A): 17,750 (derivative) @ $0EDGAR
2026-03-054Lochner Daniel — Chief Financial OfficerGrant/award (A): 26,500 @ $0 · Grant/award (A): 24,250 (derivative) @ $0EDGAR
2026-03-054REICIN ALISE — Chief Executive Officer, DirectorGrant/award (A): 76,500 @ $0 · Grant/award (A): 69,250 (derivative) @ $0EDGAR
2026-03-054/AREICIN ALISE — Chief Executive Officer, DirectorPurchase (P): 2,500 @ $21.10EDGAR
2026-02-124Schwabish Marc — Chief Business OfficerOption exercise (M): 4,500 @ $2.38 · Option exercise (M): 4,500 (derivative)EDGAR
2026-02-124REICIN ALISE — Chief Executive Officer, DirectorPurchase (P): 2,500 @ $21.10EDGAR
2026-02-114Lochner Daniel — Chief Financial OfficerPurchase (P): 6,000 @ $21.61EDGAR
2026-02-104Ruddy Marcella K. — Chief Medical OfficerTax withholding (F): 2,064 @ $23.22EDGAR
2026-02-104McNamara Peter — Chief Scientific OfficerTax withholding (F): 1,748 @ $23.22EDGAR
2026-02-104Schwabish Marc — Chief Business OfficerTax withholding (F): 1,619 @ $23.22EDGAR
2026-02-104Lochner Daniel — Chief Financial OfficerTax withholding (F): 2,077 @ $23.22EDGAR
2026-02-104REICIN ALISE — Chief Executive Officer, DirectorTax withholding (F): 4,104 @ $23.22EDGAR
2026-01-054REICIN ALISE — Chief Executive Officer, DirectorOption exercise (M): 10,966 @ $2.38 · Option exercise (M): 10,966 (derivative)EDGAR
2025-12-294McNamara Peter — Chief Scientific OfficerOption exercise (M): 7,000 @ $2.98 · Option exercise (M): 7,000 (derivative)EDGAR
2025-09-294Ruddy Marcella K. — Chief Medical OfficerGrant/award (A): 5,370 @ $0 · Grant/award (A): 9,750 (derivative) @ $0EDGAR
2025-09-294McNamara Peter — Chief Scientific OfficerGrant/award (A): 4,550 @ $0 · Grant/award (A): 8,260 (derivative) @ $0EDGAR
2025-09-294Schwabish Marc — Chief Business OfficerGrant/award (A): 4,210 @ $0 · Grant/award (A): 7,650 (derivative) @ $0EDGAR
2025-09-294Lochner Daniel — Chief Financial OfficerGrant/award (A): 5,430 @ $0 · Grant/award (A): 9,860 (derivative) @ $0EDGAR
2025-09-294REICIN ALISE — Chief Executive Officer, DirectorGrant/award (A): 14,700 @ $0 · Grant/award (A): 26,710 (derivative) @ $0EDGAR
2025-06-244REICIN ALISE — Chief Executive Officer, DirectorTax withholding (F): 859 @ $19.81EDGAR
2025-06-114MCGUIRE TERRANCE — DirectorGrant/award (A): 10,200 (derivative) @ $0EDGAR
2025-06-114SPRINGER TIMOTHY A — Director, 10% ownerGrant/award (A): 10,200 (derivative) @ $0EDGAR

Recent 8-K events — Tectonic Therapeutic, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-058-K2.01 — Completion of Acquisition or Disposition of Assets
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-298-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-108-K5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-078-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-238-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-268-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-248-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-10-308-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=TECX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs